Is Nordson Corporation (NDSN) overvalued or fairly valued?

MarketChacha shows Nordson Corporation's valuation in context — a trailing P/E of about 35.6, a forward P/E of about 24.6, a price-to-book of about 5.4 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Nordson Corporation's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.33×) from reported figures — education, not a rating.

What is Nordson Corporation's revenue?

Nordson Corporation reported revenue of $2.8B for FY2025, with net profit of $484.5M, per official filings.

What is the share price of Nordson Corporation (NDSN)?

Nordson Corporation last traded at $308.69 (-0.5% on the day), as of 8/10/2026 — a delayed quote shown for education, not investment advice.

Nordson Corporation

NDSN · NYSE · Industrials · United States

Snapshot

TickerNDSN

ExchangeNYSE

SectorIndustrials

IndustrySpecialty Industrial Machinery

CountryUnited States

Employees8,200

HeadquartersWestlake, United States

Websitewww.nordson.com

Filings tracked12

About Nordson Corporation

Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The Industrial Precision Solutions segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems; components and systems for thermoplastic and biopolymer melt stream; fluid components, such as nozzles, pumps, and filters; smart components that measure and control the flow, quantity and location of dispensed fluid; control systems; and product assembly solutions. It also offers automated and manual dispensing products and systems for cold materials, container coating, liquid finishing, and powder coating, as well as ultraviolet equipment. The Medical and Fluid Solutions segment offers precision manual and semi-automated dispensers, plastic molded syringes, cartridges, tips, and fluid connection components; interventional solutions for engineered shafts and interventional delivery systems, medical tubing, balloons, balloon inflators, nitinol devices, cardiovascular cannula, and biomaterial delivery; medical fluid components; and microplegia myocardial protection devices and related consumables. The Advanced Technology Solutions segment provides automated dispensing systems for high-speed, precise application of various attachment, protection, and coating fluids, and related gas plasma treatment systems; destructive and non-destructive testing technologies, such as bond testers and automated optical, acoustic microscopy, and x-ray inspection systems used in the semiconductor and printed circuit board industries; and precision measurement and control technologies. The company markets its products through direct sales force, distributors, and sales representatives. Nordson Corporation was founded in 1909 and is headquartered in Westlake, Ohio.

Who owns it

Insiders5.6%
Institutions76.4%
Public & other18.0%

1,025 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.7.43%
Vanguard Capital Management LLC6.19%
State Street Corporation5.34%
Vanguard Portfolio Management LLC4.21%
Kayne Anderson Rudnick Investment Management LLC3.67%
Geode Capital Management, LLC2.77%
Morgan Stanley2.59%
Invesco Ltd.1.72%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.33×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend18.5% → 17.4%

Margin has held broadly steady over the period — stable profitability.

Return on equity15.9%

Latest ROE of 15.9% — capital is generating a healthy return.

Growth qualityrev 3% · PAT -0%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $794.0M · EPS 3.28

Est. earnings growth +8.3%

Next fiscal year

Rev $3.1B · EPS 12.55

Est. earnings growth +8.3%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$2.8B

Net margin

17.4%

ROE

15.9%

Revenue CAGR (2y)

+3.1%

Profit CAGR (2y)

-0.3%

EPS (FY2025)

8.51

Net profit (FY2025)

$484.5M

Ask MarketChacha about NDSN

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$2.8B	$484.5M	8.51	17.4%	15.9%
FY2024	$2.7B	$467.3M	8.11	17.4%	15.9%
FY2023	$2.6B	$487.5M	8.46	18.5%	18.8%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$740.8M	$117.3M	2.09	15.8%
2026Q1	$669.5M	$133.4M	2.38	19.9%
2025Q3	$741.5M	$125.8M	2.22	17.0%
2025Q2	$682.9M	$112.4M	1.97	16.5%
2025Q1	$615.4M	$94.7M	1.65	15.4%
2024Q3	$661.6M	$117.3M	2.04	17.7%
2024Q2	$650.6M	$118.2M	2.05	18.2%
2024Q1	$633.2M	$109.6M	1.90	17.3%
2023Q3	$648.7M	$127.9M	2.22	19.7%
2023Q2	$650.2M	$127.6M	2.21	19.6%
2023Q1	$610.5M	$104.3M	1.81	17.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Material financial obligation
SEC6/3/2026material
10-Q filing
SEC5/21/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC5/20/2026material
8-K — Shareholder vote results
SEC3/4/2026material
10-Q filing
SEC2/19/2026
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC2/18/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC2/2/2026material

2025

10-K filing
SEC12/17/2025
8-K — Results of operations, Reg FD disclosure, Exhibits
SEC12/10/2025material
8-K — Executive/director change, Exhibits
SEC10/28/2025material
10-Q filing
SEC8/21/2025
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC8/20/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.